fior-markets-logo.jpg
Global Respiratory Care Devices Market Is Expected to Reach USD 41.20 Billion by 2027 : Fior Markets
10 avr. 2020 05h15 HE | Fior Markets
Newark, NJ, April 10, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global respiratory care devices market is expected to grow from USD 23.03 billion in 2019 and to reach...
Reports and Data.jpeg-01
Respiratory Care Devices Market To Reach USD 37.04 Billion By 2027 | Reports and Data
02 avr. 2020 15h00 HE | Reports and Data
New York, April 02, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Respiratory Care Devices Market valued at USD 18.41 Billion in 2019 and is expected to...
gmi logo.jpg
Durable Medical Equipment Market worth over USD 275 Bn by 2026: Global Market Insights, Inc.
05 mars 2020 04h00 HE | Global Market Insights, Inc
Selbyville, Delaware, March 05, 2020 (GLOBE NEWSWIRE) -- Global Market Insights, Inc. has recently added a new report on durable medical equipment market which estimates the global market...
Logo.jpg
Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®
02 mars 2020 07h30 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, March 02, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced it has filed an 8K with the Securities and Exchange...
Logo.jpg
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
24 févr. 2020 13h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
fior-markets-logo.jpg
Global Sleep Apnea Devices Market is Expected to Reach USD 10.6 Billion by 2025 : Fior Markets
21 févr. 2020 11h00 HE | Fior Markets
Newark, NJ, Feb. 21, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global sleep apnea devices market is expected to grow from USD 5.2 Billion in 2017 to USD 10.6 Billion...
Logo.jpg
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
14 janv. 2020 09h00 HE | Endonovo Therapeutics, Inc.
● This furthers Endonovo’s strategy to commercialize and protect its Electroceutical(s)® Los Angeles, CA, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or...
Logo.jpg
Endonovo Therapeutics Provides SofPulse® To All NFL Teams
23 déc. 2019 08h30 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Logo.jpg
Endonovo Therapeutics Announces Reverse Stock Split
31 oct. 2019 12h43 HE | Endonovo Therapeutics, Inc.
 Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement...
Logo.jpg
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
30 sept. 2019 09h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to...